Advanced search
Publication Cover
Hearing, Balance and Communication Volume 12, 2014 - Issue 2
Journal homepage
106
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Tinnitus in patients on therapy with proton pump inhibitors (PPI) and in PPI non-users

Antonio PiroddaDepartment of Experimental, Diagnostic and Specialty Medicine, ItalyCorrespondence[email protected]
,
Maria Chiara RaimondiDepartment of Experimental, Diagnostic and Specialty Medicine, Italy
,
Arrigo Francesco Giuseppe CiceroDepartment of Medical and Surgical Sciences, University of Bologna, Italy
,
Martina RosticciDepartment of Medical and Surgical Sciences, University of Bologna, Italy
,
Elisa Rebecca RinaldiDepartment of Medical and Surgical Sciences, University of Bologna, Italy
,
Lara BellacosaDepartment of Medical and Surgical Sciences, University of Bologna, Italy
,
Vincenzo StanghelliniDepartment of Medical and Surgical Sciences, University of Bologna, Italy
&
Claudio BorghiDepartment of Medical and Surgical Sciences, University of Bologna, Italy
 show all
Pages 84-87 | Accepted 04 Mar 2014, Published online: 05 May 2014

References

  • Shargorodsky J, Curhan GC, Farwell WR. Prevalence and characteristics of tinnitus among US adults. Am J Med. 2010;123:711–8.
  • Michikawa T, Nishiwaki Y, Kikuchi Y, Saito H, Mizutari K, Okamoto M, et al. Prevalence and factors associated with tinnitus: a community based study of Japanese elders. J Epidemiol. 2010;20: 271–6.
  • Borghi C, Brandolini C, Prandin MG, Dormi A, Modugno GC, Pirodda A. Prevalence of tinnitus in patients with hypertension and the impact of different antihypertensive drugs on the incidence of tinnitus: a prospective, single-blind, observational study. Curr Ther Res. 2005;66:<>420–32.
  • Pirodda A, Brandolini C, Raimondi MC, Modugno GC, Borghi C. Gastric type proton pump in the inner ear: its possible involvement in labyrinthine disorders. Audiol Med. 2008;6:249–50.
  • Pirodda A, Brandolini C, Raimondi MC, Modugno GC. The possible role of proton pumps inhibitors of homeostasis of the inner ear. Med Hypotheses. 2009;72:325–6.
  • Pirodda A, Modugno GC, Manzari L, Raimondi MC, Brandolini C, Ferri GG, Borghi C. Ménière's disease and the use of proton pump inhibitors. Swiss Med Wkly. 2010;140:13104.
  • Pirodda A, Raimondi MC, Ferri GG, Sammartano AM, Albera R. Proton pump inhibitors: a possible effect on Ménière's Disease?Audiol Med. 2012;10:178–81.
  • Pirodda A, Brandolini C, Raimondi MC, Ferri GG, Modugno GC, Borghi C. Ménière's disease: update of aetiopathogenetic theories and proposal of a possible model of explanation. Acta Clin Belg. 2010;65:170–5.
  • Borghi C, Cosentino ER, Rinaldi ER, Brandolini C, Raimondi MC, Veronesi M, et al. Tinnitus in elderly patients and prognosis of mild-to-moderate congestive heart failure: a cross-sectional study with a long-term extension of the clinical follow-up. BMC Med. 2011;9:80.
  • Lasisi AO, Abiona T, Gureje O. Tinnitus in the elderly: profile, correlates, and impact in the Nigerian study of ageing. Otolaryngol Head Neck Surg. 2010;143:510–5.
  • Horn JR, Howden CW. Review article: similarities and differences among delayed-release proton-pump inhibitor formulations. Aliment Pharmacol Ther. 2005;22(Suppl 3): 20–4.
  • Metz DC, Vakily, M, Dixit T, Mulford D. Review article: dual delayed release formulation of dexslansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy. Aliment Pharmacol Ther. 2009;29:928–37.
  • Shin JM, Kim N. Pharmacokinetics and pharmacodynamics of the proton pump inhibitors. J Neurogastroenterol Motil. 2013;19:25–35.
  • Naseri E, Yenisehirli A. Proton pump inhibitors omeprazole and lansoprazole induce relaxation of isolated human arteries. Eur J Pharmacol. 2006;531:226–31.
  • Yenisehirli A, Naseri E. Omeprazole, lansoprazole and pantoprazole had no effect on blood pressure and electrocardiogram of anaesthetized rat. Pharmacol Res. 2008; 58:65–71.
  • Handa O, Yoshida N, Fujita N, Tanaka Y, Ueda M, Takagi T, et al. Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors. Inflamm Res. 2006;55:476–80.
  • Nakagawa S, Aral Y, Kishida T, Hiraoka N, Tsuchida S, Inoue H, et al. Lansoprazole inhibits nitric oxide and prostaglandin E(2) production in murine macrophage RAW 264.7 cells. Inflammation. 2012;35:1062–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.